| [1] |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74:229-263.
|
| [2] |
Hendriks D, Brouwers JF, Hamer K, et al. Engineered human hepatocyte organoids enable CRISPR-based target discovery and drug screening for steatosis[J]. Nat Biotechnol, 2023,41:1567-1581.
|
| [3] |
Sachs N, Ligt J D, Kopper O, et al. A living biobank of breast cancer organoids captures disease heterogeneity[J]. Cell, 2018, 172:373. doi: 10.1016/j.cell.2017.11.010.
|
| [4] |
Driehuis E, Kretzschmar K, Clevers H. Establishment of patient-derived cancer organoids for drug-screening applications[J]. Nat Protoc, 2020,15:3380-3409.
|
| [5] |
Huch M, Dorrell C, Boj SF, et al. In vitro expansion of single lgr5+ liver stem cells induced by Wnt-driven regeneration[J]. Nature, 2013,494:247-250.
|
| [6] |
Kim S, Min S, Choi YS,et al. Tissue extracellular matrix hydrogels as alternatives to Matrigel for culturing gastrointestinal organoids[J]. Nat Commun, 2022,13:1692. doi: 10.1038/s41467-022-29279-4.
|
| [7] |
Smyth EC, Vlachogiannis G, Hedayat S, et al. EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers[J]. Gut,2021,70:1632-1641.
|
| [8] |
Liu J, MacNaughtan J, Kerbert AJC, et al. Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis[J]. Gut,2024,73:1183-1198.
|
| [9] |
Liu M, Zhang C, Gong X, et al. Kidney organoid models reveal cilium-autophagy metabolic axis as a therapeutic target for PKD both in vitro and in vivo[J]. Cell Stem Cell,2024,31:52-70.
|
| [10] |
Li Y, Tang S, Shi X, et al. Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer[J]. Cell Rep Med,2023,4:101162. doi: 10.1016/j.xcrm.2023.101162.
|
| [11] |
Bi G, Zhang X, Li W, et al. Modeling alcohol-associated liver disease in humans using adipose stromal or stem cell-derived organoids[J]. Cell Rep Methods,2024,4:100778. doi: 10.1016/j.crmeth.2024.100778.
|
| [12] |
Braakhuis HM, Gremmer ER, Bannuscher A, et al. Transferability and reproducibility of exposed air-liquid interface co-culture lung models[J]. NanoImpact,2023,31:100466. doi: 10.1016/j.impact.2023.100466.
|
| [13] |
Park DS, Kozaki T, Tiwari SK, et al. IPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer[J]. Nature,2023,623:397-405.
|
| [14] |
Dayton TL, Alcala N, Moonen L, et al. Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites[J]. Cancer Cell,2023,41:2083-2099.
|
| [15] |
Zhao H, Cheng Y, Kalra A, et al. Generation and multiomic profiling of a TP53/CDKN2A double-knock-out gastroesophageal junction organoid model[J]. Sci Transl Med,2022,14:eabq6146. doi: 10.1126/scitranslmed.abq6146.
|
| [16] |
Guillen KP, Fujita M, Butterfield AJ, et al. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology[J]. Nat Cancer,2022,3:232-250.
|
| [17] |
Vlachogiannis G, Hedayat S, Vatsiou A, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers[J]. Science, 2018,359:920-926.
|
| [18] |
Zhou Z, Van der Jeught K, Fang Y, et al. An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity[J]. Nat Biomed En,2021,5:1320-1335.
|
| [19] |
Lv T, Shen L, Xu X, et al. Patient-derived tumor organoids predict responses to irinotecan-based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer[J]. Int J Cancer,2023,152:524-535.
|
| [20] |
Chen P, Zhang X, Ding R, et al. Patient-derived organoids can guide personalized-therapies for patients with advanced breast cancer[J]. Adv Sci (Weinh),2021,8:e2101176. doi: 10.1002/advs.202101176.
|
| [21] |
Farin HF, Mosa MH, Ndreshkjana B, et al. Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses[J]. Cancer Discov,2023,13:2192-2211.
|
| [22] |
Ahn Y, An JH, Yang HJ, et al. Human blood vessel organoids penetrate human cerebral organoids and form a vessel-like system[J]. Cells,2021,10:2036. doi: 10.3390/cells10082036.
|
| [23] |
Li Y, Liu S, Zhou K, et al. Neuromedin U programs eosinophils to promote mucosal immunity of the small intestine[J]. Science,2023,381:1189-1196.
|
| [24] |
Hu Y, Sui X, Song F, et al. Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week[J]. Nat Commun,2021,12:2581. doi: 10.1038/s41467-021-22676-1.
|
| [25] |
González-Callejo P, Vázquez-Aristizabal P, García-Astrain C, et al. 3D bioprinted breast tumor-stroma models for pre-clinical drug testing[J]. Mater Today Bio,2023,23:100826. doi: 10.1016/j.mtbio.2023.100826.
|
